← Back to News · 1 outlet · Story cluster #2256

NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI

How different outlets framed the same story — bias, verdict, and framing side by side.

🤖 D.R.A.F.T. Summary

NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Acc

TORONTO, May 04, 2026 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced the appointment of Dr.

Outlets covering this story

Montreal Gazette CENTER

Only one perspective covered this story — no diversity detected

📰

Side-by-Side Outlet Comparison — Starter+

See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.

Unlock with Starter →

See plans